| Literature DB >> 33225375 |
Xianrong Liang1, Zhujiang Tan, Guojun Yun, Jianguo Cao, Jinggang Wang, Qing Liu, Turong Chen.
Abstract
OBJECTIVE: The results of previous research into exercise interventions for children with cerebral palsy are inconsistent. The aim of this study is to assess the effectiveness of such exercise interventions.Entities:
Keywords: cerebral palsy; child; exercise; meta-analysis; systematic review
Mesh:
Year: 2021 PMID: 33225375 PMCID: PMC8814858 DOI: 10.2340/16501977-2772
Source DB: PubMed Journal: J Rehabil Med ISSN: 1650-1977 Impact factor: 2.912
Fig. 1Flow diagram of study selection process.
Characteristics of studies included in the meta-analysis
| Study | Country | Sample size, | Mean age, years | Males, % | Disease status | Measurement tool | Intervention | Control | Outcomes | Follow-up, months |
|---|---|---|---|---|---|---|---|---|---|---|
| Dodd et al. 2003 ( | Australia | 21 | 13.0 | 47.6 | GMFCS levels I-III | ICF and GMFM | Resistance training | Normal activities | Gross motor function: 69.0 vs 75.3; gait speed: 0.8 m/s vs 0.84 m/s; muscle strength: 33.1 vs 25.5 | 6.0 |
| Engsberg et al. 2006 ( | USA | 12 | 9.9 | 25.0 | GMFCS levels I-III | GMFM | Resistance training | No strength training | Gross motor function: 69.0 vs 71.4; gait speed: 0.91 m/s vs 0.79 m/s | 3.0 |
| Unger et al. 2006 ( | South Africa | 37 | 16.0 | 61.3 | GMFCS levels I-III | Three-dimensional gait analysis | Resistance training | Normal school and therapy programme | Gait speed: 1.119 m/s vs 1.17 m/s | 2.0 |
| Liao et al. 2007 ( | China | 20 | 7.4 | 60.0 | GMFCS levels I, II | GMFM | Resistance training | Regular physiotherapy programme | Gross motor function: 82.7 vs 80.6; gait speed: 1.012 m/s vs 0.98 m/s; muscle strength: 6.1 vs 6.2 | 1.5 |
| Seniorou et al. 2007 ( | UK | 20 | 12.5 | 50.0 | GMFCS levels I-III | GMFM | Resistance training | Identical programme performed with no weights | Gross motor function: 55.6 vs 60.8; gait speed: 0.3 m/s vs 0.3 m/s; muscle strength: 1.3 vs 1.2 | 6.0 |
| Unnithan et al. 2007 ( | Greece | 13 | 15.8 | 30.8 | GMFCS levels I-III | GMFM | Mixed training | Normal physical therapy | Gross motor function: 33.85 vs 30.76 | 3.0 |
| Verschuren et al. 2007 ( | The Netherlands | 68 | 12.2 | 64.7 | GMFCS levels I, II | GMFM | Mixed training | Usual care | Gross motor function: 87.24 vs 90.11; muscle strength: 37.44 vs 38.48 | 12.0 |
| Lee et al. 2008 ( | Korea | 17 | 6.3 | 58.8 | GMFCS levels II, III | GMFM | Resistance training | Conventional physiotherapy | Gross motor function: 62.7 vs 61.4; gait speed: 0.746 m/s vs 0.68 m/s; muscle strength: 13.2 vs 14.1 | 2.6 |
| Fowler et al. 2010 ( | USA | 62 | 11.4 | 46.8 | GMFCS levels I-III | GMFM | Aerobic training | No cycling | Gross motor function: 70.8 vs 69.3; gait speed: 1.133 m/s vs 1.04 m/s; muscle strength: 0.89 kg vs 0.86 kg | 3.0 |
| Reid et al. 2010 ( | Australia | 14 | 11.0 | 42.9 | GMFCS levels I-III | Biodex dynamometer | Resistance training | Normal activity | Muscle strength: 184.71 vs 211.81 | 1.5 |
| Scholtes et al. 2010 ( | The Netherlands | 51 | 10.4 | 56.9 | GMFCS levels I-III | GMFM | Resistance training | Conventional physiotherapy programme | Gross motor function: 76.1 vs 73.1; gait speed: 1.03 m/s vs 1.07 m/s; muscle strength: 5.39 vs 4.48 | 4.0 |
| Gharib et al. 2011 ( | Egypt | 30 | 11.6 | 53.3 | GMFCS level II | The Biodex Gait Trainer 2TM | Aerobic training | Identical programme performed with physical therapy exercise | Gait speed: 0.67 m/s vs 0.63 m/s | 3.0 |
| Johnston et al. 2011 ( | USA | 34 | 9.5 | 53.8 | GMFCS levels II-IV | GMFM | Aerobic training | Strengthening exercise | Gross motor function: 63.3 vs 60.1; gait speed: 0.62 m/s vs 0.50 m/s; muscle strength: 3.58 vs 3.80 | 4.0 |
| Smania et al. 2011 ( | Italy | 18 | 13.3 | 55.6 | GMFCS levels I-IV | WeeFIM | Aerobic training | Usual physiotherapy | Gait speed: 0.97 m/s vs 0.82 m/s | 1.5 |
| Olama et al. 2011 ( | Egypt | 30 | 13.7 | 60.0 | NA | Bruininks- Oseretsity test | Aerobic training | Both groups received an exercise programme | Gross motor function: 44.09 vs 46.69; muscle strength: 29.50 vs 30.15 | 6.0 |
| Pandey et al. 2011 ( | India | 18 | NA | 61.1 | NA | Lateral step up test | Resistance training | None were allowed to attend physiotherapy | Gait speed: 0.70 m/s vs 0.60 m/s; muscle strength: 6.3 vs 2.67 | 1.0 |
| Chrysagis et al. 2012 ( | Greece | 22 | 16.0 | 59.1 | GMFCS levels I-III | GMFM | Aerobic training | Conventional physiotherapy | Gross motor function: 71.67 vs 65.13; gait speed: 0.997 m/s vs 0.78 m/s | 3.0 |
| Bryant et al. 2013 ( | UK | 35 | 13.8 | 40.0 | GMFCS levels IV and V | GMFM | Aerobic exercise | Usual physiotherapy | Gross motor function: 1.87 vs 0.20 | 4.0 |
| Chen et al. 2013 ( | China | 30 | 8.6 | 66.7 | GMFCS levels I-II | GMFM | Aerobic training | General physical activity at home | Gross motor function: 84.2 vs 81.0; muscle strength: 1.63 kg vs 1.35 kg | 3.0 |
| Mattern- Baxter et al. 2013 ( | USA | 12 | 1.8 | 66.7 | GMFCS levels I-II | GMFM | Aerobic training | Weekly scheduled physiotherapy sessions | Gross motor function: 16.9 vs 13.89; gait speed: 0.699 m/s vs 2.40 m/s | 4.0 |
| Lee et al. 2015 ( | Korea | 26 | 6.5 | 50.0 | GMFCS levels I-III | GMFM | Resistance training | General neurodevelopmental treatment | Gross motor function: 81.9 vs 81.3 | 1.5 |
| Mitchell et al. 2016 ( | Australia | 101 | 11.8 | 51.5 | GMFCS levels I-II | 6MWT | Mixed training | Usual care | Muscle strength: 63.5 vs 46.8 | 5.0 |
| Cleary et al. 2017 ( | Australia | 19 | 13.8 | 52.6 | GMFCS levels I-III | 6MWT | Aerobic training | Social/art activities | Muscle strength: 52.2 vs 24.7 | 5.0 |
| Peungsuwan et al. 2017 ( | Thailand | 15 | 13.3 | 53.3 | GMFCS levels I-III | 6MWT | Resistance training | Usual care | Gait speed: 1.11 m/s vs 0.99 m/s; muscle strength: 11.13 vs 8.43 | 2.0 |
| Gibson et al. 2018 ( | Australia | 42 | 12.5 | 64.3 | GMFCS levels I-III | GAS | Aerobic training | Usual care | Muscle strength: 25.6 vs 16.5 | 3.0 |
| Fosdahl et al. 2019 ( | Norway | 37 | 10.2 | 56.8 | GMFCS levels I-II | 6MWT | Resistance training | Usual care | Gait speed: 1.04 m/s vs 1.03 m/s | 8.0 |
| Kara et al. 2019 ( | Turkey | 30 | 11.5 | 46.7 | GMFCS levels I-III | GMFM | Resistance training | Usual care | Gross motor function: 97.22 vs 95.83; muscle strength: 4.94 vs 5.82 | 3.0 |
6MWT: Six-Minute Walk Test; GAS: Goal Attainment Scaling; GMFCS: Gross Motor Function Classification System; GMFM: Gross Motor Function Measure; ICF: International Classification of Functioning, Disability and Health; NA: not available; WeeFIM: Functional Independence Measure for Children.
Quality assessment of included studies
| Study | Randomization | Blindness | Concealment of treatment allocation | Completeness of follow-up | ITT analysis | Total score |
|---|---|---|---|---|---|---|
| Dodd et al. 2003 ( | 1 | 1 | 0 | 1 | 1 | 4 |
| Engsberg et al. 2006 ( | 1 | 0 | 0 | 0 | 0 | 1 |
| Unger et al. 2006 ( | 1 | 0 | 0 | 0 | 0 | 1 |
| Liao et al. 2007 ( | 0 | 1 | 0 | 0 | 0 | 1 |
| Seniorou et al. 2007 ( | 1 | 0 | 0 | 1 | 0 | 2 |
| Unnithan et al. 2007 ( | 0 | 0 | 0 | 1 | 1 | 2 |
| Verschuren et al. 2007 ( | 0 | 1 | 1 | 1 | 1 | 4 |
| Lee et al. 2008 ( | 1 | 0 | 0 | 0 | 0 | 1 |
| Fowler et al. 2010 ( | 1 | 0 | 0 | 1 | 1 | 3 |
| Reid et al. 2010 ( | 0 | 0 | 0 | 1 | 1 | 2 |
| Scholtes et al. 2010 ( | 1 | 0 | 0 | 1 | 1 | 3 |
| Gharib et al. 2011 ( | 0 | 1 | 0 | 1 | 1 | 3 |
| Johnston et al. 2011 ( | 1 | 0 | 0 | 0 | 0 | 1 |
| Smania et al. 2011 ( | 1 | 0 | 0 | 1 | 1 | 3 |
| Olama et al. 2011 ( | 1 | 0 | 0 | 0 | 0 | 1 |
| Pandey et al. 2011 ( | 1 | 0 | 0 | 0 | 0 | 1 |
| Chrysagis et al. 2012 ( | 1 | 1 | 0 | 1 | 0 | 3 |
| Bryant et al. 2013 ( | 0 | 0 | 0 | 1 | 1 | 2 |
| Chen et al. 2013 ( | 1 | 0 | 0 | 0 | 0 | 1 |
| Mattern-Baxter et al. 2013 ( | 0 | 0 | 0 | 1 | 1 | |
| Lee et al. 2015 ( | 0 | 0 | 0 | 1 | 1 | 2 |
| Mitchell et al. 2016 ( | 1 | 0 | 1 | 1 | 1 | 4 |
| Cleary et al. 2017 ( | 1 | 0 | 0 | 1 | 1 | 3 |
| Peungsuwan et al. 2017 ( | 1 | 0 | 0 | 1 | 0 | 2 |
| Gibson et al. 2018 ( | 1 | 1 | 0 | 1 | 1 | 4 |
| Fosdahl et al. 2019 ( | 1 | 1 | 0 | 1 | 1 | 4 |
| Kara et al. 2019 ( | 1 | 1 | 0 | 1 | 0 | 3 |
1: low risk; 0: high risk; ITT: intention-to-treat
Fig. 2Effect of exercise intervention on gross motor function in children with cerebral palsy. 95% CI: 95% confidence interval.
Effect of exercise intervention on gross motor function, gait speed, and muscle strength when a study is omitted
| Study omitted | Gross motor function, WMD (95% CI) | Gait speed, WMD (95% CI) | Muscle strength, WMD (95% CI) |
|---|---|---|---|
| Dodd et al. 2003 ( | 1.31 (–0.97 to 3.59) | 0.06 (0.01 to 0.11) | 0.89 (0.16 to 1.61) |
| Engsberg et al. 2006 ( | 1.23 (–1.05 to 3.51) | 0.05 (0.00 to 0.10) | – |
| Unger et al. 2006 ( | – | 0.06 (0.01 to 0.11) | – |
| Liao et al. 2007 ( | 1.05 (–1.39 to 3.49) | 0.05 (0.00 to 0.11) | 1.04 (0.26 to 1.83) |
| Seniorou et al. 2007 ( | 1.25 (–1.03 to 3.53) | 0.06 (0.01 to 0.12) | 1.07 (0.18 to 1.97) |
| Unnithan et al. 2007 ( | 1.16 (–1.13 to 3.44) | – | – |
| Verschuren et al. 2007 ( | 1.92 (–0.54 to 4.38) | – | 0.93 (0.20 to 1.66) |
| Lee et al. 2008 ( | 1.19 (–1.08 to 3.46) | 0.05 (0.00 to 0.11) | 0.95 (0.21 to 1.68) |
| Fowler et al. 2010 ( | 1.13 (–1.36 to 3.62) | 0.05 (–0.00 to 0.10) | 1.10 (0.16 to 2.05) |
| Reid et al. 2010 ( | – | – | 0.92 (0.19 to 1.65) |
| Scholtes et al. 2010 ( | 0.97 (–1.43 to 3.37) | 0.06 (0.01 to 0.11) | 0.93 (0.12 to 1.74) |
| Gharib et al. 2011 ( | – | 0.06 (–0.00 to 0.12) | – |
| Johnston et al. 2011 ( | 1.15 (–1.13 to 3.44) | 0.05 (0.00 to 0.10) | 0.97 (0.23 to 1.72) |
| Smania et al. 2011 ( | – | 0.05 (–0.00 to 0.10) | – |
| Olama et al. 2011 ( | 1.24 (–1.04 to 3.52) | – | 0.99 (0.25 to 1.74) |
| Pandey et al. 2011 ( | – | 0.05 (–0.01 to 0.10) | 0.37 ( –0.06 to 0.80) |
| Chrysagis et al. 2012 ( | 1.05 (–1.24 to 3.35) | 0.04 (–0.00 to 0.08) | – |
| Bryant et al. 2013 ( | 1.14 (–1.24 to 3.52) | – | – |
| Chen et al. 2013 ( | 1.01 (–1.36 to 3.38) | – | 1.04 (0.17 to 1.90) |
| Mattern-Baxter et al. 2013 ( | 1.10 (–1.23 to 3.42) | 0.05 (0.02 to 0.09) | – |
| Lee et al. 2015 ( | 1.22 (–1.09 to 3.52) | – | – |
| Mitchell et al. 2016 ( | – | – | 0.82 (0.13 to 1.51) |
| Cleary et al. 2017 ( | – | – | 0.91 (0.19 to 1.64) |
| Peungsuwan et al. 2017 ( | – | 0.05 (–0.00 to 0.10) | 0.79 (0.06 to 1.53) |
| Gibson et al. 2018 ( | – | – | 0.91 (0.19 to 1.64) |
| Fosdahl et al. 2019 ( | – | 0.06 (0.00 to 0.11) | – |
| Kara et al. 2019 ( | 1.18 (–1.15 to 3.51) | – | 0.89 (0.14 to 1.64) |
95% CI: 95% confidence interval; WMD: weighted mean difference.
Subgroup analyses for investigated outcomes
| Outcomes | Factors | Groups | WMD and 95% CI | Heterogeneity, % | |||
|---|---|---|---|---|---|---|---|
| Gross motor function | Country | Eastern | 2.22 (-2.21 to 6.65) | 0.326 | 0.0 | 0.987 | 0.596 |
| Western | 0.83 (-1.81 to 3.46) | 0.538 | 0.0 | 0.983 | |||
| Mean age, years | > 12.0 | -0.71 (-4.69 to 3.26) | 0.725 | 0.0 | 0.852 | 0.252 | |
| < 12.0 | 2.11 (-0.65 to 4.87) | 0.133 | 0.0 | 1.000 | |||
| Percentage male, % | > 50.0 | 1.21 (-1.63 to 4.05) | 0.403 | 0.0 | 0.963 | 0.984 | |
| < 50.0 | 1.16 (-2.60 to 4.93) | 0.545 | 0.0 | 0.975 | |||
| Exercise type | Resistance | 1.46 (-2.24 to 5.15) | 0.440 | 0.0 | 0.987 | 0.390 | |
| Aerobic | 2.25 (-1.11 to 5.61) | 0.189 | 0.0 | 0.993 | |||
| Mixed | -2.22 (-7.71 to 3.28) | 0.429 | 0.0 | 0.507 | |||
| Follow-up, months | > 6.0 | -3.24 (-8.47 to 1.98) | 0.224 | 0.0 | 0.985 | 0.065 | |
| < 6.0 | 2.22 (-0.29 to 4.73) | 0.084 | 0.0 | 1.000 | |||
| Study quality | High | -3.19 (-8.73 to 2.36) | 0.260 | 0.0 | 0.726 | 0.090 | |
| Low | 2.07 (-0.41 to 4.55) | 0.102 | 0.0 | 1.000 | |||
| Gait speed | Country | Eastern | 0.10 (0.02 to 0.17) | 0.016 | 0.0 | 0.966 | 0.209 |
| Western | 0.04 (-0.02 to 0.11) | 0.194 | 43.5 | 0.053 | |||
| Mean age, years | > 12.0 | 0.06 (-0.03 to 0.16) | 0.202 | 53.9 | 0.055 | 0.519 | |
| < 12.0 | 0.04 (-0.03 to 0.11) | 0.285 | 12.7 | 0.328 | |||
| Percentage male, % | > 50.0 | 0.05 (-0.00 to 0.11) | 0.068 | 41.8 | 0.056 | 0.826 | |
| < 50.0 | 0.07 (-0.07 to 0.21) | 0.352 | 0.0 | 0.727 | |||
| Exercise type | Resistance | 0.03 (-0.02 to 0.08) | 0.237 | 0.0 | 0.763 | 0.169 | |
| Aerobic | 0.10 (-0.02 to 0.22) | 0.112 | 63.4 | 0.018 | |||
| Follow-up, months | > 6.0 | -0.00 (-0.08 to 0.07) | 0.990 | 0.0 | 0.960 | 0.122 | |
| < 6.0 | 0.07 (0.01 to 0.13) | 0.024 | 36.3 | 0.092 | |||
| Study quality | High | -0.00 (-0.15 to 0.14) | 0.980 | 0.0 | 0.775 | 0.459 | |
| Low | 0.06 (0.01 to 0.12) | 0.032 | 37.1 | 0.079 | |||
| Muscle strength | Country | Eastern | 1.37 (-0.50 to 3.24) | 0.152 | 92.7 | < 0.001 | < 0.001 |
| Western | 0.38 (-0.20 to 0.96) | 0.205 | 53.0 | 0.015 | |||
| Mean age, years | > 12.0 | 0.77 (-0.73 to 2.28) | 0.312 | 32.9 | 0.177 | < 0.001 | |
| < 12.0 | 0.37 (-0.20 to 0.93) | 0.204 | 61.2 | 0.008 | |||
| Percentage male, % | > 50.0 | 1.04 (0.04 to 2.03) | 0.042 | 85.1 | < 0.001 | < 0.001 | |
| < 50.0 | 0.20 (-0.62 to 1.01) | 0.639 | 7.1 | 0.358 | |||
| Exercise type | Resistance | 1.34 (0.08 to 2.60) | 0.037 | 87.6 | < 0.001 | < 0.001 | |
| Aerobic | 0.06 (-0.13 to 0.25) | 0.526 | 0.0 | 0.781 | |||
| Mixed | 7.83 (-9.56 to 25.21) | 0.377 | 85.7 | 0.008 | |||
| Follow-up, months | > 6.0 | 0.09 (-0.34 to 0.53) | 0.682 | 0.0 | 0.560 | 0.356 | |
| < 6.0 | 1.17 (0.22 to 2.11) | 0.015 | 87.4 | < 0.001 | |||
| Study quality | High | 7.85 (-1.52 to 17.22) | 0.101 | 57.2 | 0.072 | 0.008 | |
| Low | 0.80 (0.11 to 1.50) | 0.024 | 85.7 | < 0.001 |
95% CI: 95% confidence interval; WMD: weighted mean difference
Fig. 3Effect of exercise intervention on gait speed in children with cerebral palsy. 95% CI: 95% confidence interval.
Fig. 4Effect of exercise intervention on muscle strength in children with cerebral palsy. 95% CI: 95% confidence interval.